Les Sinclair talks with Dr. Amrie Grammer about AMPEL BioSolutions, a Charlottesville Virginia company that has reengineered the gene-based technology they developed for lupus to COVID19.

A local Charlottesville company has developed a new approach to predicting the severity of the Coronavirus. Kathryn Young at CBS brings you the story.